Clinical Trial Update: Post Market Surveillance Study Evaluating BioFoam Surgical Matrix in Cardiovascular Surgery

View source ↗

Summary

A post-market surveillance study assessing the safety and performance of BioFoam Surgical Matrix in various cardiovascular procedures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Dissection
• Aortic Valve Disease
• Thoracic Aortic Aneurysm

Drugs mentioned

• BioFoam Surgical Matrix

Snippet

Sponsor: CryoLife Europa | Conditions: Cardiovascular Procedures, Thoracic Aortic Aneurysm | Status: COMPLETED